Jul 2026
Identification of a prognostic signature based on expression of post-translational modification-related genes in acute myeloid leukemia.
BACKGROUND Acute myeloid leukemia (AML) features high biological heterogeneity and unfavorable prognoses, demanding reliable prognostic biomarkers. Dysregulated post-translational modifications (PTMs) drive AML progression by disrupting protein function and cellular signaling. This work constructed a PTM-based risk sig...
D. Gan, Jin-fang Zeng, Jun Lin et al.
· Japanese Journal of Clinical... · 0 citations